Company delivered all-time record results across multiple metrics including revenue (+33%), adjusted EPS (+35%), adjusted EBITDA (+48%), and operating cash flows (+25%). Contractor Solutions achieved positive organic growth for the second consecutive quarter. Strong execution on capital allocation strategy with $1 billion in accretive acquisitions, successful share repurchases, dividend increases, and balance sheet de-leveraging. Management expressed confidence in continued growth through fiscal 2027.
The company declared a regular quarterly dividend, reported record quarterly and full year results for fiscal 2026, and achieved positive organic growth in the Contractor Solutions segment. Additionally, a promotion of an executive was announced to support continued growth strategy, indicating strong operational performance and management confidence.
Despite near-term earnings headwinds from integration costs and soft organic volumes, the company demonstrates a proven decade-long acquisition playbook with strong historical returns (19% incremental FCF yield on deployed capital). The current pullback to 17x forward EBITDA offers attractive entry for patient capital. Management's track record, strong contractor-channel moat with high switching costs, and clear path to normalized $300M+ EBITDA support a positive long-term outlook, though near-term execution risks exist around MARS/Aspen integration and organic volume recovery.
Also mentions CSW
Articles that tag CSW but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
